Well Referenced

Tag: growth hormone therapy

Brain Recovery after a Plane Crash: Treatment with Growth Hormone (GH) and Neurorehabilitation: A Case Report

This case report describes a young male patient who suffered severe traumatic brain injury (TBI) following a plane crash, resulting in spastic tetraplegia, dysarthria, dysphagia, cognitive deficits, and joint deformities. Fifteen months post-injury, the patient commenced a regimen of growth hormone (GH) therapy at 1 mg/day administered in three-month intervals

Read More »
June 26, 2025 No Comments

Growth Hormone Therapy in Heart Failure

This 2018 review by Salzano et al. explores the therapeutic potential of growth hormone (GH) replacement in patients with chronic heart failure (CHF), a condition often associated with acquired GH deficiency. The authors outline how GH and its mediator IGF-1 influence myocardial function, vascular tone, and metabolic regulation. Although animal

Read More »
June 26, 2025 No Comments

Discussion: Growth Hormone Therapy Accelerates Axonal Regeneration, Promotes Motor Reinnervation, and Reduces Muscle Atrophy following Peripheral Nerve Injury

This 2016 expert commentary by Sando and Cederna discusses the implications of preclinical research by Tuffaha et al., which demonstrated that growth hormone (GH) therapy significantly enhances peripheral nerve regeneration in a rat model of sciatic nerve transection and repair. Daily subcutaneous administration of GH (0.4 mg/day) improved axonal regeneration,

Read More »
June 26, 2025 No Comments

Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone

This study compared the effectiveness of growth hormone-releasing hormone (GHRH(1-29)-NH₂) with standard growth hormone (GH) therapy in promoting growth in children with hypothalamic growth hormone deficiency (GHD). High-dose GHRH(1-29)-NH₂ significantly increased height velocity, comparable to GH treatment, but had no effect on bone age development. GHRH(1-29)-NH₂ did not induce GH

Read More »
June 26, 2025 No Comments

Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29

This study investigated the effects of dopaminergic, adrenergic, and cholinergic blockade, along with TRH administration, on growth hormone (GH) responses to growth hormone-releasing factor (GRF) 1-29. It was found that these neurotransmitter systems modulate GH secretion in response to GRF, and TRH administration also influenced GH release. The study highlights

Read More »
June 26, 2025 No Comments

A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency

This 1993 randomized controlled trial titled “A Comparative Study of Growth Hormone (GH) and GH-Releasing Hormone(1-29)-NH₂ for Stimulation of Growth in Children with GH Deficiency” (Acta Paediatrica Supplement, DOI: [10.1111/j.1651-2227.1993.tb12834.x]*) evaluated 60 children with hypothalamic GH deficiency, comparing growth outcomes with either GH therapy or low- and high-dose GHRH(1-29)-NH₂ over

Read More »
June 26, 2025 No Comments

Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults

The study “Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults” examines the effects of growth hormone (GH) therapy on metabolic processes and thyroid function in adults with GH deficiency. The findings indicate

Read More »
June 26, 2025 No Comments

Early Life Interventions Can Shape Aging

This study investigates the impact of early-life hormonal interventions on aging using Ames dwarf mice, which are growth hormone (GH) deficient and exhibit extended lifespans. GH injections administered twice daily from two to eight weeks of age normalized several metabolic traits associated with longevity, suggesting that early-life GH therapy may

Read More »
June 26, 2025 No Comments